# Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function

> **NCT00600912** · PHASE4 · COMPLETED · sponsor: **Klinikum Ludwigshafen** · enrollment: 42 (actual)

## Conditions studied

- Inflammatory Response
- Hepatic Function

## Interventions

- **DRUG:** SMOFlipid®
- **DRUG:** 2-ClinOleic 20%®

## Key facts

- **NCT ID:** NCT00600912
- **Lead sponsor:** Klinikum Ludwigshafen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2009-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600912, "Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00600912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*